Efficacy, Safety and Tolerability of KLU156 in Adults and Children With Uncomplicated P. Falciparum Malaria

NCT05842954 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1720

Enrollment

INDUSTRY

Sponsor class

Conditions

Uncomplicated Plasmodium Falciparum Malaria

Interventions

DRUG: KLU156
DRUG: Coartem

Sponsor

Novartis Pharmaceuticals

Collaborators

[object Object]